Tuberculosis is associated with non-tuberculosis-related deaths among HIV/AIDS patients in Rio de Janeiro

Int J Tuberc Lung Dis. 2014 Dec;18(12):1473-8. doi: 10.5588/ijtld.14.0181.

Abstract

Setting: Human immunodeficiency virus (HIV) infected patients followed in a large cohort in Rio de Janeiro, Brazil.

Objective: To evaluate the association of tuberculosis (TB) and other covariables with non-TB-related (NTR) causes of death (CODs).

Design: Patients aged >18 years were followed from 1997 to 2009, until death or 31 December 2009, whichever was earlier. CODs were ascertained using a standardised algorithm. TB diagnosis and prophylaxis followed Brazilian guidelines. Poisson models were used to calculate adjusted rate ratios (aRRs).

Results: Of 2887 patients included in the study, 761 had TB (26.4%). NTR death rates were twice as high among patients with TB (4/100 vs. 2.09/100 patient-years). TB was associated with NTR deaths (aRR 1.4, 95%CI 1.05-1.86, P = 0.01). Highly active antiretroviral treatment (HAART) was protective against NTR (aRR 0.46, 95%CI 0.34-0.61, P < 0.001). Among patients who had never had active TB, prophylaxis was also protective against NTR (aRR 0.45, P = 0.04). The CD4 cell count increase was very modest for both TB and NTR CODs compared to those who did not die (0 vs. 249 cells, P < 0.001).

Conclusions: TB was significantly associated with increased NTR CODs, indicating rapid progression of disease and increased long-term risk of mortality, probably related to persistent immunodeficiency or incomplete immune recovery. Our results confirm the benefits of HAART and TB prophylaxis.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Antitubercular Agents / therapeutic use
  • Brazil / epidemiology
  • Cause of Death
  • Chi-Square Distribution
  • Coinfection*
  • Databases, Factual
  • Disease Progression
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • HIV Infections / mortality*
  • Humans
  • Immunocompromised Host
  • Male
  • Middle Aged
  • Odds Ratio
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Tuberculosis / diagnosis
  • Tuberculosis / immunology
  • Tuberculosis / mortality*
  • Tuberculosis / prevention & control
  • Urban Health*

Substances

  • Anti-HIV Agents
  • Antitubercular Agents